CIDP Brasil, a CRO and clinical research institute specialized in dermatology, will present an innovative photographic atlas of melasma spots on the face at IFSCC. Using standardised photographs, the material illustrates the clinical and subclinical differences of melasma, covering the most common phototypes of the Brazilian population (III, IV and V). The aim of the atlas is to improve the evaluation and reproducibility of clinical studies and to be an essential visual reference for increasing the accuracy of clinical studies on melasma.

According to CIDP Brazil's medical director, Renato Moura, the inclusion of cross-polarised images allows visualisation beyond what is visible to the naked eye, highlighting important details especially in darker skins, where melanin differentiation is more challenging. ‘The cosmetics industry is increasingly facing the challenge of demonstrating the efficacy and tolerance of its products for all skin types. Melasma is even more frequent in the brown and black population, where its colour intensity is greater. The lack of representation of these more pigmented skins in studies and scientific references on melasma makes this work pioneering, offering an inclusive approach that reflects the diversity of the Brazilian population,’ says Moura, who is responsible for creating the atlas and is also a member of the Brazilian Society of Dermatology (SBD). 

Melasma is a type of brown spot that appears on the skin in areas exposed to the sun, especially on the face. SBD data shows that this condition affects 35% of Brazilian women between the ages of 20 and 60. The photographic atlas will be presented during the IFSCC, an event to be held between 14 and 17 October in Foz do Iguaçu. For Moura, the event provides a unique opportunity to present methodological innovations in clinical research and for the industry to explore new possibilities for studies aimed at guaranteeing the quality and safety of cosmetic products. 

“Our diversity of phototypes and ethnicities represents a challenge, but also a unique opportunity to understand how depigmenting treatments work on different skin types, making a significant contribution to cosmetic innovation. Taking part in the IFSCC opens doors to international collaborations and strengthens the competitiveness of the Brazilian cosmetics industry on the global stage,” he concludes.


About CDIP

CIDP Brazil is part of the CIDP group, which has 20 years' experience in clinical research and a strong presence on several continents. With headquarters in Mauritius and affiliates in India and in Romania, as well as Brazil, more specifically in Rio de Janeiro, the group provides segmented services in five main areas: Research and Innovation, Pre-clinical Trials, Clinical Trials, Statistics and Regulatory Affairs. Find out more about CIDP Brazil by visiting stand 48 at IFSCC.

 

Back to top